Clinical Trial Detail

NCT ID NCT01923337
Title Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

colorectal cancer

Advanced Solid Tumor

Therapies

Alisertib + Irinotecan

Age Groups: senior adult

No variant requirements are available.